Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | PTAFR | P25105 | 1/20 | 0.40 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.40 |
| ▸ | GBA1 | P04062 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24940224 | 1.00 | EPHX1 (0.53) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL18660923 | 1.00 | EPHX1 (0.53) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL19933291 | 1.00 | EPHX1 (0.53) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL20443960 | 1.00 | EPHX1 (0.53) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL10445292 | 1.00 | EPHX1 (0.53) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL6423756 | 0.98 | EPHX1 (0.50) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL23773071 | 0.92 | EPHX1 (0.42) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL19935766 | 0.89 | EPHX1 (0.50) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL21160596 | 0.89 | EPHX1 (0.50) | EPHX1ALDH1A1PPARGCYP1A2PTAFR | |
| SCHEMBL20011814 | 0.89 | EPHX1 (0.50) | EPHX1ALDH1A1PPARGCYP1A2PTAFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4215064-A1 | NOVEL FLAVOR, FLAVOR COMPOSITION, AND PRODUCT INCLUDING SAME | KT & G Corporation (KR) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023090904-A1 | SMOKING ARTICLE COMPRISING NOVEL FLAVORANT | 주식회사 케이티앤지 | 2023-05-25 | — | — | WO | disclosed |
| US-6939845-B2 | Fragrance precursors | GIVAUDAN SA (CH) | 2005-09-06 | — | — | US | disclosed |
| EP-1167362-B1 | Fragance precursors | GIVAUDAN SA (CH) | 2005-05-25 | — | — | EP | disclosed |
| US-20020035055-A1 | Fragrance precursors | GIVAUDAN SA (CH) | 2002-03-21 | — | — | US | disclosed |
| EP-1167362-A1 | Fragance precursors | Givaudan SA (CH) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035055-A1 | Fragrance precursors | FAAH2, FDPS, CYP51A1 | EPHX1 448/4885ALDH1A1 26/4885PPARG 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.